比较布塞索尼德治疗异敏性食道炎的情况:一个专门的中心队列与一个基于人口的队列队列
Line Tegtmeier Frandsen1,2, Katrine Krogh Sørensen2,3, Lasse Ellingsøe Vistisen2,3
1Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.
Scandinavian journal of gastroenterology
|October 26, 2024
概括
这项研究比较了专门和基于人口的队列,以酸性食道炎 (EoE) 治疗与布德森化口腔可分散片 (BOT) 的治疗. 结果显示,缓解率相似,这表明高度专业化的中心没有明确的优势,尽管相互矛盾的反应仍然令人担忧.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 性食道炎 (EoE) 是一种慢性免疫介导的食道疾病.
- 布德索尼德口溶性片 (BOT) 是EoE推的二线治疗方法.
- 了解专业和基于人口的队列之间的治疗差异和结果对于优化患者护理至关重要.
研究的目的:
- 为了比较在开服布索尼德口溶性片 (BOT) 之前的治疗差异.
- 评估BOT治疗期间的后续实践和临床组织学缓解率.
- 评估高度专业化的EoE队列 (EoE-Cph) 和基于人口的队列 (DanEoE) 之间遵守国家指南.
主要方法:
- 一项队列研究将65名来自EoE-Cph的成年患者与65名来自DanEoE的成年患者进行比较,诊断时间在2015-2021年之间.
- 根据AGREE共识确认了EoE的诊断.
- 从医疗记录和注册表中手动提取的数据.
主要成果:
- 在BOT启动之前使用质子抑制剂 (PPI) 有显著差异 (88%EoE-Cph与100%DanEoE,p=0.0035).
- 症状随访率是相似的 (89%的EoE-Cph与97%的DanEoE相比,p=0.0841).
- 完全临床-组织学缓解率相似 (67%的EoE-Cph与80%的DanEoE,p=0.1789),四分之一的患者表现出相互矛盾的反应.
结论:
- 该研究没有提供确的证据表明,高度专业化的EdE中心与基于人口的环境相比,提供了优越的治疗结果.
- 需要进一步的研究,以告知临床实践中关于EOE管理的潜在变化.
- 相互矛盾的治疗反应和因副作用而中止治疗是EoE管理中的重大问题.
相关概念视频
Barrett Esophagus-II: Clinical Manifestations and Management
112
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
112
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
223
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
223
COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
240
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
240


